Quoin Pharmaceuticals
Ashburn
About Quoin Pharmaceuticals
Quoin Pharmaceuticals is into developing products which address major unmet medical needs including the opioid epidemic and the military veteran suicide rate and chronic rare skin diseases such as Netherton syndrome and Dystrophic Epidermolysis Bullosa (DEB).
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Total funding: $125.0M
- Funding stage: IPO
- Last round: Post-IPO Equity (Oct 2025)
- Ticker: nasdaq:QNRX
- Website: quoinpharma.com
- Phone: 972 58-448-8821
Industries & Categories
Biotechnology, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/quoin-pharmaceuticals-111993 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.